![Kerry Wentworth](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kerry Wentworth
General Counsel at
NUVATION BIO INC.
Net worth: 253 340 $ as of 31/05/2026
Profile
Ms. Kerry A. Wentworth is a Chief Regulatory Officer at Nuvation Bio, Inc. She is on the Board of Directors at Massachusetts Biotechnology Council.
Ms. Wentworth was previously employed as a Chief Regulatory Officer by Flexion Therapeutics, Inc., a Vice President-Clinical, Regulatory & Quality by Agenus, Inc., a Senior Director-Regulatory Affairs by Genelabs Technologies, Inc., and a Head-Regulatory Affairs by Genzyme Corp.
She received her undergraduate degree from the University of New Hampshire.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 17/04/2026 | 53,000 ( 0.02% ) | 253 340 $ | 31/05/2026 |
Kerry Wentworth active positions
| Companies | Position | Start |
|---|---|---|
| NUVATION BIO INC. | General Counsel | 18/07/2022 |
Massachusetts Biotechnology Council
 Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Director/Board Member | 01/04/2019 |
Former positions of Kerry Wentworth
| Companies | Position | End |
|---|---|---|
| FLEXION THERAPEUTICS, INC. | General Counsel | 19/11/2021 |
| AGENUS INC. | Chief Tech/Sci/R&D Officer | 10/07/2014 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | General Counsel | - |
Genelabs Technologies, Inc.
 Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products and performs life science research and development | General Counsel | - |
Training of Kerry Wentworth
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
62
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Genelabs Technologies, Inc.
Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products and performs life science research and development | Health Technology |
Agenus, Inc.
 Agenus, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of technologies to treat cancers and infectious diseases | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Flexion Therapeutics, Inc.
 Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of patients with musculoskeletal conditions | Health Technology |
University of New Hampshire
 University of New Hampshire Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Commercial Services |
Nuvation Bio, Inc.
 Nuvation Bio, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops oncology related novel therapeutic candidates | Health Technology |
- Stock Market
- Insiders
- Kerry Wentworth
